Emerson Electric (EMR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
4 Aug, 2026Executive summary
Q3 2026 delivered outstanding results with net sales of $4.9B, up 7% year-over-year, and underlying sales up 6%, driven by robust demand in growth verticals, especially Software & Systems, and strong operational execution in North America and Asia.
Adjusted EPS rose 13% year-over-year to $1.71, with GAAP EPS up 24% to $1.28, and net earnings for Q3 at $718M.
Free cash flow in Q3 was $1.32B, up 36% year-over-year, with a margin of 27.1%.
Full-year 2026 guidance was raised for sales, EPS, and cash flow, reflecting continued healthy demand and strong Q3 performance.
CTO Peter Zornio retired, with Rudy Sengupta appointed as Chief Technology and AI Officer to reinforce AI-enabled automation strategy.
Financial highlights
Q3 2026 adjusted segment EBITA margin expanded to 28.5%, up 140 basis points year-over-year.
Adjusted EPS grew 13% year-over-year to $1.71, above guidance.
Free cash flow for Q3 was $1.32B, up 36% year-over-year, with a margin of 27.1%.
Backlog ended at $8.2B, up 7% year-over-year.
Q3 gross profit was $2.66B (54.5% margin), up 11% year-over-year.
Outlook and guidance
Full-year 2026 net sales growth expected at ~5% GAAP and ~3.5% underlying, with FX adding 1.5%.
Adjusted segment EBITA margin guidance at ~28%.
Adjusted EPS guidance raised to ~$6.55; GAAP EPS expected at ~$4.89.
Free cash flow for the year expected at ~$3.6B; operating cash flow at ~$4.1B.
Q4 adjusted EPS expected at ~$1.85.
Latest events from Emerson Electric
- Targeting $21B sales, 30% EBITA margin, $8.00 EPS, and $10B shareholder returns by 2028.EMR
Investor Update9 Jul 2026 - Proposing full AspenTech acquisition, reviewing Safety & Productivity sale, and boosting shareholder returns.EMR
Q4 20248 Jul 2026 - Q3 sales rose 11%, adjusted EPS up 11%, and Copeland exit boosted debt reduction plans.EMR
Q3 20248 Jul 2026 - Director elections, compensation, and auditor ratification passed; board declassification failed.EMR
AGM 20268 Jul 2026 - Q2 sales and EPS rose, led by Test & Measurement, with robust 2026 outlook and capital returns.EMR
Q2 202611 May 2026 - Q1 2026 delivered 4% sales growth, 6% EPS growth, and raised guidance on strong automation demand.EMR
Q1 202617 Apr 2026 - Order growth, AI-driven automation, and software rebound underpin strong long-term outlook.EMR
JPMorgan Industrials Conference 202617 Mar 2026 - AI-driven software growth and robust U.S. demand fuel strong performance and future outlook.EMR
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Strong order growth, innovation, and high margins drive a positive outlook and investor confidence.EMR
Barclays 43rd Annual Industrial Select Conference17 Feb 2026